- Home
- FINW vs DERM Comparison
FINW vs DERM Comparison
Compare FINW & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FINW
- DERM
- Stock Information
- Founded
- FINW 1999
- DERM 2014
- Country
- FINW United States
- DERM United States
- Employees
- FINW N/A
- DERM N/A
- Industry
- FINW Commercial Banks
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- FINW Finance
- DERM Health Care
- Exchange
- FINW Nasdaq
- DERM Nasdaq
- Market Cap
- FINW 196.2M
- DERM 181.0M
- IPO Year
- FINW 2021
- DERM 2021
- Fundamental
- Price
- FINW $15.67
- DERM $7.10
- Analyst Decision
- FINW Buy
- DERM Strong Buy
- Analyst Count
- FINW 4
- DERM 2
- Target Price
- FINW $20.75
- DERM $10.00
- AVG Volume (30 Days)
- FINW 76.0K
- DERM 178.0K
- Earning Date
- FINW 07-24-2025
- DERM 08-11-2025
- Dividend Yield
- FINW N/A
- DERM N/A
- EPS Growth
- FINW N/A
- DERM N/A
- EPS
- FINW 0.91
- DERM N/A
- Revenue
- FINW $72,056,000.00
- DERM $56,243,000.00
- Revenue This Year
- FINW $38.17
- DERM $28.99
- Revenue Next Year
- FINW $18.44
- DERM $52.61
- P/E Ratio
- FINW $17.21
- DERM N/A
- Revenue Growth
- FINW 7.66
- DERM N/A
- 52 Week Low
- FINW $10.29
- DERM $3.54
- 52 Week High
- FINW $20.94
- DERM $8.25
- Technical
- Relative Strength Index (RSI)
- FINW 66.33
- DERM 52.70
- Support Level
- FINW $13.81
- DERM $6.63
- Resistance Level
- FINW $14.37
- DERM $7.28
- Average True Range (ATR)
- FINW 0.55
- DERM 0.38
- MACD
- FINW 0.22
- DERM 0.03
- Stochastic Oscillator
- FINW 89.53
- DERM 83.02
About FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.